Abstract
References
Articles referenced by this article (25)
Title not supplied
2005
Nigral and extranigral pathology in Parkinson's disease.
J Neural Transm Suppl, 15-31 1995
MED: 8821039
Title not supplied
2007
Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation.
Ann Neurol, (3):313-319 2001
MED: 11261505
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
Neuron, (4):601-607 2004
MED: 15541309
PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.
Arch Neurol, 333-359 1964
MED: 14107684
Adams RD Salam-Adams M Striatonigral degeneration Vinken PJ Bruyn GW Klawans HL Handbook of clinical neurology. Extrapyramidal disorders 49 New York Elsevier 1986 205 212
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.
Ann Neurol, (4):598-605 1999
MED: 10514096
Show 10 more references (10 of 25)
Citations & impact
Impact metrics
Citations of article over time
Article citations
Function and Mechanism of Abscisic Acid on Microglia-Induced Neuroinflammation in Parkinson's Disease.
Int J Mol Sci, 25(9):4920, 30 Apr 2024
Cited by: 0 articles | PMID: 38732130 | PMCID: PMC11084589
Review Free full text in Europe PMC
Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases.
Neural Regen Res, 19(6):1241-1248, 22 Sep 2023
Cited by: 7 articles | PMID: 37905870 | PMCID: PMC11467914
Review Free full text in Europe PMC
Bidirectional association between Parkinson's disease and obstructive sleep apnea: a cohort study.
J Clin Sleep Med, 19(9):1615-1623, 01 Sep 2023
Cited by: 2 articles | PMID: 37185062 | PMCID: PMC10476034
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease.
Biomater Res, 27(1):46, 16 May 2023
Cited by: 6 articles | PMID: 37194005 | PMCID: PMC10190035
Review Free full text in Europe PMC
"Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications.
Aging Cell, 21(4):e13575, 09 Mar 2022
Cited by: 6 articles | PMID: 35262262 | PMCID: PMC9009237
Review Free full text in Europe PMC
Go to all (58) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
[Inflammation and Parkinson's disease].
Rev Neurol, 38(6):545-553, 01 Mar 2004
Cited by: 0 articles | PMID: 15054720
Review
Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
Neuroscience, 138(3):869-878, 05 Dec 2005
Cited by: 115 articles | PMID: 16337092
Review
Glial reactions in Parkinson's disease.
Mov Disord, 23(4):474-483, 01 Mar 2008
Cited by: 437 articles | PMID: 18044695
Review
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
Ann N Y Acad Sci, 1057:296-318, 01 Dec 2005
Cited by: 35 articles | PMID: 16399902
Review
Funding
Funders who supported this work.
MDA/Wings Over Wall Street
NIA NIH HHS (1)
Grant ID: R01 AG21617
NIH/NINDS (2)
Grant ID: RO1 AG21617
Grant ID: P01 NS11766-27A1
NINDS NIH HHS (2)
Grant ID: P50 NS38370
Grant ID: P01 NS11766-27A1
Parkinsons Disease Foundation, USA
US Department of Defense (1)
Grant ID: DAMD 17-03-1
Udall Parkinson's Disease Research (1)
Grant ID: P50 NS38370